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Abstract
Background: Older people in poor health are more likely to need extra money, aids and adaptations to allow them to
remain independent and cope with ill health, yet in the UK many do not claim the welfare benefits to which they are
entitled. Welfare rights advice interventions lead to greater welfare income, but have not been rigorously evaluated for
health benefits. This study will evaluate the effects on health and well-being of a domiciliary welfare rights advice service
provided by local government or voluntary organisations in North East England for independent living, socio-
economically disadvantaged older people (aged ≥60 yrs), recruited from general (primary care) practices.
Methods/Design: The study is a pragmatic, individually randomised, single blinded, wait-list controlled trial of welfare
rights advice versus usual care, with embedded economic and qualitative process evaluations. The qualitative study will
examine whether the intervention is delivered as intended; explore responses to the intervention and examine reasons
for the trial findings; and explore the potential for translation of the intervention into routine policy and practice. The
primary outcome is the effect on health-related quality of life, measured using the CASP 19 questionnaire. Volunteer
men and women aged ≥60 years (1/household) will be identified from general practice patient registers. Patients in
nursing homes or hospitals at the time of recruitment will be excluded. General practice populations will be recruited
from disadvantaged areas of North East England, including urban, rural and semi-rural areas, with no previous access to
targeted welfare rights advice services delivered to primary care patients. A minimum of 750 participants will be
randomised to intervention and control arms in a 1:1 ratio.
Discussion: Achieving a trial design that is both ethical and acceptable to potential participants, required
methodological compromises. The choice of follow-up length required a trade-off between sufficient time to
demonstrate health impact and the need to allow the control group access to the intervention as early as possible. The
study will have implications for fundamental understanding of social inequalities and how to tackle them, and provides
a model for similar evaluations of health-orientated social interventions. If the health benefits of this intervention are
proven, targeted welfare rights advice services should be extended to ensure widespread provision for older people and
other vulnerable groups.
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Background
Socio-economic inequalities in health, income and older
people
Health inequalities are universal across nations, societies
and the human lifecourse [1-3]. Socio-economic differ-
ences in health persist into old age and social inequal-
ities in self-reported physical and mental health widen in
early old age [4]. The poorest older people have inad-
equate access to services essential to health and well-
being [5]. Older people, especially those in poor health,
are more likely to require additional income and sup-
port, including payments for care, domestic help and
aids and adaptations to the home [6-8].
Resource-based interventions to promote health
The vast body of evidence on socio-economic inequalities
in health suggests a close relationship between access to
resources and health status. Increasing an individual's or
group's access to material, social or financial resources
should result in improved health [9,10], yet little research
has directly evaluated the impact of increasing resources
on health [11]. A systematic review of ten North American
randomised controlled trials of income supplementation
experiments targeting a range of age groups, carried out in
the late 1960s and 1970s, showed that none had reliably
assessed the effects of increased income on health. The
authors pointed out that, although such experiments are
unlikely to be repeated, one way of assessing the health im-
pact of increasing financial resources on health lies with
assisting claimants to obtain full welfare benefit entitle-
ments [11]. Tackling health inequalities has become a
major policy priority for the UK government, highlighted,
for example, in the white paper on public health (‘Saving
Lives: Our Healthier Nation’). Following publication of the
‘Acheson Report’ [2] and the advent of Health Action
Zones (HAZs) in the late 1990s [12], there was an increase
in welfare rights advice projects linked to primary care in
the UK. A voluntary organisation estimated in 2000 that
there were >130 welfare rights advice services targeting
primary care patients in England [13]. In 1999, 'Reducing
Health Inequalities: an Action Report' [14], highlighted
welfare rights advice as a potentially effective intervention
to reduce health inequalities. This proposal was endorsed
by the UK Government’s ‘Marmot Review’ in 2012 [3].
Social welfare for older people and under-claiming of
entitlement
In the UK, large amounts of social welfare benefits go
unclaimed [15,16], and a disproportionate amount of
these are the health-related benefit entitlements of vul-
nerable groups, such as older people [17,18]. Failure to
claim entitlements is linked to a number of factors in-
cluding the complexity of the benefits system [19], lack
of knowledge about entitlements and difficulty in
making claims [8,20-22]. In addition to the state pen-
sion, there are a number of means-tested and non-
means-tested benefits that can be awarded if entitlement
conditions are fulfilled. The level of under-claiming var-
ies depending on the benefit concerned, but is estimated
to be at least 30 % for the main benefits [23]. Entitle-
ment to one benefit can often act as a ‘passport’ to
others, since many of the benefits aimed at people over
national retirement age are linked together in a complex
network of entitlements that are often difficult for
people to access without expert assistance.
Welfare rights advice services and their evaluation
Our systematic review of the health, social and economic
impacts of welfare rights advice services in healthcare set-
ting [21], identified numerous studies that have demon-
strated the financial and material benefits of such services.
Welfare rights advice provided by local authorities, char-
ities and voluntary organisations is known to increase up-
take of benefits, particularly where this involves ‘active
assistance’ with benefit claims [2,17]. Studies have also
shown that receipt of benefit entitlements can be increased
by providing information and advice in general practice,
particularly in relation to those benefits that are health-
related [24-28]. However, our systematic review only iden-
tified two studies that have investigated the health impact
of welfare rights advice; [29-31] one of which found an im-
provement in health-related quality of life in some of the
subscales of the SF36 [29,30]. However, both studies dem-
onstrate the difficulties of identifying and measuring ap-
propriate health outcome measures when assessing the
health effects of welfare rights advice in primary care [29-
31]. Neither study used a randomised controlled design,
and both suffered from significant methodological weak-
nesses that render them inconclusive. Qualitative studies
exploring the impact of welfare rights advice on clients in
primary care identified a range of health-related outcomes
that can potentially result from receipt of welfare rights ad-
vice, including changes in physical, behavioural and, in par-
ticular, psycho-social domains of health [8,20-22].
We conducted a pilot randomised controlled trial
(RCT) to prepare for the definitive RCT described here,
evaluating the impact of a domiciliary welfare rights ad-
vice service offered to people aged ≥60 years, identified
via primary care in disadvantaged areas [7,8,32]. This
pilot trial increased uptake of financial (median gain
£55/week) and non-financial benefits (e.g. aids and adap-
tations to the home) in 58 % of participants [7], confirm-
ing the feasibility and success of the intervention from
the point of view of accessing unclaimed benefits. It also
provided vital information on the feasibility of such a
trial, which has helped in planning the current definitive
RCT.
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Welfare rights (WR) advice interventions lead to
greater income, but have not been rigorously evaluated
for health benefits, in part because such research has
previously been deemed unethical [33]. We present the
protocol for a definitive RCT of WR Advice for people
aged ≥60 years, and discuss the methodological and eth-
ical issues that needed to be taken into account in
designing the trial. We identified challenges relating to:
randomisation, contamination, equipoise and control
condition, length of follow-up, selection bias, outcome
measures, generalisability and nature of the intervention.
These are analysed in relation to scientific and ethical
considerations.
Objectives
The proposed RCT with embedded economic and quali-
tative process evaluations aims to answer the following
questions:
1. What are the effects on health-related quality of life
of a domiciliary welfare rights advice service
targeting independent-living, socio-economically
disadvantaged older people (aged ≥60 yrs) identified
via primary care?
2. What are the cost consequences and what is the
cost-effectiveness of a domiciliary welfare rights
advice service targeting independent-living older
people (aged ≥60 yrs) identified via primary care?
3. What is the acceptability to trial participants and
relevant professionals of a domiciliary welfare rights
advice service targeting independent-living older
people (aged ≥60 yrs) identified via primary care?
4. What are the unanticipated consequences (positive
or negative) of a domiciliary welfare rights advice
service targeting independent-living older people
(aged ≥60 yrs) identified via primary care?
Study Design
The study is a pragmatic, individually randomised, single
blinded, wait-list controlled trial of welfare rights advice
versus usual care, with embedded economic and qualita-
tive process evaluations. The qualitative study will exam-
ine whether the intervention is delivered as intended,
explore responses to the intervention and examine rea-
sons for the trial findings, and explore feasibility of the
translation of the intervention into routine policy and
practice. The trial design is illustrated in Figure 1, which
has been drawn according to the CONSORT guidelines
[34].
Primary outcome measure
The primary outcome is quality of life, measured using
the CASP 19 questionnaire which was developed for use
with older people [35,36]. CASP stands for the four
domains of Control, Autonomy, Self realization and
Pleasure. CASP 19 will be administered by face-to-face
interview at baseline (pre-randomisation) and at follow-
up 24 months post-randomisation, and by postal ques-
tionnaire at 12 months post-randomisation.
Secondary outcome measures
The following secondary outcomes, based on the find-
ings of previous research, including our own systematic
review, qualitative study and pilot trial [7,8,20-22,32,37]
will be collected:
 Health status, measured by the EuroQoL (EQ5D)
[38]
 Functional ability measured by the modified
Townsend activities of daily living scale [39]
 Independence categorised as: living independently or
with carer support, in own home, with relations,
care home or hospital (the latter two categories at
follow-up only)
 Mental health measured by the PHQ-9 depression
questionnaire [40-42]
 Health-related behaviours assessed by self-report to
measure change in key indicator behaviours, such as
smoking, alcohol consumption, diet (consumption of
key food groups) and physical activity, as in our pilot
RCT [7]
 Mortality assessed by identifying deaths at 12 months
and 24 months from GP records (we will do this prior
to commencing follow-up assessments, so as not to
attempt to contact the recently deceased, which may
cause distress to bereaved relations)
 Social support and participation measured by the
Social Support Questionnaire [43].
 Perceived financial wellbeing measured by the
Affordability Index [44].
 Fuel poverty measured where a household can achieve
temperatures needed to maintain health and comfort
for expenditure of less than 10 % of income [45]
 Financial status measured by a standard assessment
tool developed and used in our pilot RCT [7]. This
includes data on all sources of household income,
including benefits, major outgoings (rent/mortgage,
fuel bills etc.), debts and capital assets (i.e. home and
savings). As well as these data, at follow-up detailed
data will be collected (by WR Advisors) on new
benefits received since baseline, including one-off
(lump sum) payments and regular, weekly or monthly
income.
 Material (dis)advantage measured through standard
questions to ascertain home ownership, size of
home (number of ‘living’ rooms), car ownership,
and access to household amenities (such as central
heating, cooker, fridge, freezer, etc.).
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These outcomes will be assessed by structured, face-
to-face interview at baseline (pre-randomisation) and
24 months post-randomisation.
Other quantitative data to be collected
As well as demographic factors including age, sex, ethni-
city, marital status and living arrangements, including
dependants, data will be collected to assess the costs of
the intervention, from public sector and treasury per-
spectives (see ‘Health economic analyses’ below). The
service costs of delivering the intervention will be
assessed by collecting data on staff salaries from all par-
ticipating services, as well as data on typical caseloads.
WR Advisors routinely record information on visits to
clients and we will use these data to estimate time spent
with study clients, as well as travel costs. These data will
be used to derive an average cost per case of delivering
the intervention to our intervention group participants,
as in our pilot RCT [7]. To assess the treasury perspec-
tive, total gains in financial benefits for all intervention
clients will be provided by WR Advisors. We will also
estimate the cost to the treasury of non-financial bene-
fits based on details of successful claims provided by
WR Advisors. These costs will then be summed to de-
rive average costs to the treasury per case for all inter-
vention participants.
Study population
Randomised controlled trial
Inclusion criteria – general practices General practice
populations in disadvantaged areas of North East Eng-
land, including urban, rural and semi-rural areas, with
no previous access to targeted welfare rights advice services
delivered to primary care patients, will be included.
Assessed for eligibility (n = ) 
Excluded  (n =   ) 
Not meeting inclusion criteria (n = ) 
Declined to participate (n = ) 
Other reasons (n = ) 
Analysed (n = 319) 
Excluded from analysis (give reasons) (n = )
Lost to follow-up at 12m (give reasons) (n = ) 
Discontinued WR intervention by 12m (give 
reasons) (n = ) 
Allocated to WR intervention (n = 375) 
Received WR intervention (n = )
Did not receive WR intervention (give reasons) 
(n = )
Lost to follow-up by 12m (give reasons) (n = ) 
Allocated to control (n = 375) 
Received control intervention (n = )
Did not receive control intervention (give 
reasons) (n = )
Analysed  (n = 319) 
Excluded from analysis (give reasons) (n = )
Allocation
Analysis
Follow Up
Randomised (n = 750) 
Enrolments
Lost to follow-up at 24m (give reasons) (n = ) 
Discontinued WR intervention by 24m (give 
reasons) (n = ) Lost to follow-up by 24m (give reasons) (n = ) 
Figure 1 CONSORT 2010 standard RCT flow diagram for Do-Well study (numbers, where they appear, are estimates at this stage).
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All practices from participating social service districts will
be ranked according to deprivation score (2010 English
Index of Multiple Deprivation calculated at Middle Super
Output Area level for practice postcodes, according to the
method of Griffin et al [46].). Those practices in the lower
two fifths of the deprivation ranking distribution without
existing dedicated or targeted welfare rights advice services
will be eligible for inclusion.
Inclusion criteria - patients
 Volunteer men and women registered with a general
practice in one of 10 social services areas (1
individual per household)
 Aged ≥60 years
 Providing informed consent
Exclusion criteria - patients
 Resident in social care (residential) or nursing
homes or hospitals at the time of identification and
recruitment
 Diagnosed with terminal illness
 Cannot participate in the research by virtue of
current physical/mental health
 Lack of fluency in written and spoken English
Qualitative study
A range of professionals involved in service commission-
ing, policy and strategy will be interviewed including: (i)
public health/NHS (GP commissioning consortia); (ii)
social and welfare rights services; (iii) Pension Service,
Department for Work and Pensions; and (iv) the volun-
tary sector. Trial participants will also be purposively
selected to take part in interviews (see below).
Screening, recruitment, consent and randomisation
Identification and screening of trial participants
Practices will be recruited with the help of the Northern
and Yorkshire Primary Care Research Network (PCRN-
NY). The study will take place in 10 local authority districts
(Stockton, Darlington, Middlesbrough, County Durham,
Sunderland, South Tyneside, North Tyneside, Newcastle,
Gateshead, Northumberland) which have agreed to provide
welfare rights advice services. We plan to recruit two gen-
eral practices per local authority district. Potentially eligible
practices will be identified as described above. We will then
liaise with Welfare Rights Services to establish whether any
of these practices have existing dedicated or targeted wel-
fare rights advice services, since this will render them ineli-
gible. Next, we will ask the PCRN-NY to identify which of
the practices still eligible have indicated willingness to par-
ticipate in research. If more than two general practices
from each list have expressed willingness to participate in
research, we will order the remaining practices randomly
and then contact them sequentially until two practices
from each social services district have agreed to participate
in the trial.
General practices in North East England have access
(via PCRN-NY and the Comprehensive Local Research
Networks (CLRNs)) to personnel and financial resources
to identify and approach research study participants.
Using PCRN-NY and CLRN personnel and financial
resources, each participating practice will be asked to
generate a random sample of up to 300 people aged ≥60
from their practice register. Practice staff will scrutinise
their list to identify any patients terminally ill and
patients known to be resident in hospital or long-term
care, who will be excluded. They will also check to en-
sure that only one person per household has been
selected for this list. If 2 or more people from the same
address are found, one will be selected at random to be
retained and the other(s) removed from the sample list.
Recruitment
This list of up to 300 names per practice will be ran-
domly ordered and the first 100 patients on the list will
be sent a letter and study information sheet by their GP,
inviting participation in the trial. The letter will explain
that, unless the participant objects (by returning an opt-
out form to the practice within 2 weeks), their name and
contact details will be passed to the research team, who
will then contact them directly to discuss the trial fur-
ther and seek informed consent. Patients’ views have
been incorporated in the design of patient information
sheets and consent forms and the opt-out approach has
been approved by the Research Ethics Committee.
After two weeks, contact details of those who have not
opted out will be passed to the research team. Research
staff will contact these individuals and, if acceptable, ar-
range a face-to-face meeting at a mutually convenient time
in the participant’s own home or another location of the
participant’s choosing.
Our target for recruitment from each practice will be
predetermined (depending on the final number of prac-
tices involved) in order to achieve the total sample. If
this number is not achieved from the first 100 mailed,
subsequent mailings of further names from the list of up
to 300 will take place until the required number have
been recruited. The number to be included in subse-
quent mailings will be determined by the number of
responses already received (i.e. the yield rate of each
wave of invitations). Since recruitment interviews will be
spread over a six month period, this iterative recruit-
ment process should not delay overall recruitment.
Consent
At the initial appointment, the research interviewer will
first seek written, informed consent and then, if appro-
priate, proceed to collect baseline data. Interviewers will
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communicate in English, and if English is not the first
language of any participant and (s)he is unable to speak
it fluently, the participant will be excluded from the
study. Friends, relations or carers will not be used as
interpreters and interpreting services available to WR
Advisors from local authorities will not be available for
research interviews (the CASP19 has not been translated
to other appropriate languages nor cross-culturally
validated).
The researcher will assess if an individual has the cap-
acity to consent. If it is established that an individual is
unable to provide written consent because of literacy, vi-
sion or motor problems, it will be arranged for verbal
consent to be taken in the presence of an independent
witness (e.g. family member) who will initial, sign and
date the consent form on the participant’s behalf.
Although unlikely to be a frequent occurrence, it is
conceivable that a participant may lose mental capacity
during the follow up period. We will explain to partici-
pants at baseline that, if this happens, we will retain the
information that we gathered prior to his/her loss of
capacity. The investigator and research interviewers will
undertake all reasonable steps to protect the study par-
ticipant. In accordance with the Mental Capacity Act
2005, nothing will be done to the person to which he or
she appears to object (whether by showing signs of re-
sistance or otherwise) except where what is being done
is intended to protect him or her from harm or to re-
duce or prevent pain or discomfort.
Identification and recruitment of participants for qualitative
sub-study
Interviews with approximately 30 purposively sampled
trial participants will take place between 8–11 months
and between 20–23 months from baseline (approxi-
mately 15 interviews in each period). Trial participants
will be identified through the trial database and
recruited to achieve a maximum variation sample with
respect to group allocation, gender, age, benefit entitle-
ments and any unanticipated consequences of the inter-
vention identified at 12 month follow-up.
A sample of approximately 10 professionals/stake-
holders will also be interviewed at 20–23 months from
baseline. Stakeholders will include representatives of the
Department for Work and Pensions, Benefits Agency,
adult social services managers, welfare rights advisors,
General Practitioners (GPs), primary care commissioners
and directors of public health.
Trial participants will be asked during baseline assess-
ment and consent procedures if they would be willing to
participate in the qualitative interviews. Those selected
for interview (trial participants and professionals/stake-
holders) will be sent a letter of invitation and additional
participant information sheet by the research team.
Contact details for the researchers will be provided so
that those approached to participate can ask any ques-
tions they may have before coming to a decision on par-
ticipation. Separate informed consent will be taken for
the interviews and lack of consent to participate in this
element of the research will not prevent trial participants
from continuing in the trial.
Sampling and interviews with both groups will continue
until data saturation is achieved [47]. Interviews with trial
participants will explore: acceptability of the intervention
and research design; unanticipated consequences of the
intervention; and perceived impacts of the intervention.
Interviews with stakeholders will explore: acceptability of
the intervention, training and research; fidelity of the inter-
vention; and likely implications of the intervention for
translation into routine policy and practice, both within
the North East and more widely.
Sample size
Trial sample size and power
A minimum of 750 participants will be randomised to
intervention and control arms, providing 90 % power at
5 % significance level to detect a 1.5 unit difference in
mean CASP19 score [35,36] between intervention and
control groups, assuming a standard deviation of 8.7 and
a correlation between baseline and 24 months of 0.74
[48], and 15 % attrition over 24 months (as experienced
in our pilot RCT) [7]. There has been no published work
to establish a meaningful or clinically important differ-
ence on the CASP19 scale. However, we have used data
from two waves of the English Longitudinal Study of
Ageing in those aged ≥60 yrs to investigate the adjusted
mean difference in CASP19 at Wave 2 between groups
whose social or health circumstances had changed [48].
Examples of changes in CASP19 score associated with
changes in health or social circumstances that we might
expect to see in the proposed trial include: ‘developed lim-
iting illness’ -2.8 units; ‘developed depression’ -2.7units;
‘lost access to car’ -1.8 units; ‘increased chance will not
meet financial needs’ -1.1 units. These differences on the
CASP19 scale suggest that a difference of 1.5 units would
represent a ‘clinically’ important difference.
The chosen sample size should also provide power to
demonstrate some clinically significant differences in
secondary outcomes. For example, 750 participants will
provide 90 % power to detect a difference between a
prevalence of 11 % and 4 % of clinically significant de-
pressive symptoms (PHQ-9 score ≥10).
Qualitative sub-study sample size
Sample size for the qualitative sub-study will be deter-
mined by data saturation. We anticipate that up to 30
trial participants and up to 10 stakeholders will be
included.
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Study intervention details
Intervention
Welfare rights advice consultations and active assistance
with benefit claims will be offered and delivered in parti-
cipants’ own homes, tailored to individual needs by a
trained WR Advisor employed by a local authority or
Citizens’ Advice Bureaux (CAB) in North East England.
Following randomisation, intervention group partici-
pants will be given an appointment in their own home
with a WR Advisor within 2 weeks, during which parti-
cipants will undergo a full benefit entitlement assess-
ment involving: assessment of financial, material and
welfare status; assessment of previous benefit entitle-
ment and claims; discussion of current entitlement and
options for action, including new claims (financial and
non-financial). Active assistance with benefit claims and
other welfare issues will be given. Complex claims or
those referred for further assessment or tribunal will be
managed in the usual way by WR Advisors. Participants
will be followed up intermittently by WR Advisors until
they no longer require assistance (cases are usually
‘closed’ once all claims and appeals have been resolved
satisfactorily). It is expected that approximately 50 per
cent of claims will be resolved within 3 months, but
some may take up to 12 months [7]. The intervention
will be funded and provided by WR Advice departments
and CAB in 10 local authority areas across the North
East by trained WR Advisors.
The North East Strategic Health Authority has pro-
vided funding for training of WR Advisors to ensure a
consistent approach to delivery of the intervention. Such
training was delivered in the context of our pilot RCT
[7,8] and Newcastle City Council, Welfare Rights Service
has agreed to provide similar training for this trial.
Comparator (wait-list control condition)
Participants randomised to the control group will re-
ceive ‘usual care’ from both health and social services
after randomisation until they have completed their 24-
month follow-up assessment. They will be given no ad-
vice regarding welfare rights as a part of the study inter-
vention during this period. However, they may
independently seek welfare rights advice from the local
authority, CAB or voluntary sector organisations. If this
occurs, they will remain in the trial, but details of such
advice and ensuing claims and outcomes will be
recorded at the 24 months follow-up assessment. Fol-
lowing their 24-month follow-up assessment, they will
receive the intervention, as delivered to the intervention
group (described above), including all follow-up visits by
WR Advisors and assistance with claims and appeals
over the following months, until all claims have been
resolved.
Long-term care
Both intervention and control group participants will re-
main clients of the welfare advice service beyond the
end of the trial, if necessary, until such time as their help
is no longer needed, as per usual welfare rights advice
service protocols.
Randomisation
Following baseline measurements, participants will be
randomised in a 1:1 ratio to intervention or control con-
dition. Research interviewers will notify the project ad-
ministrator after each baseline interview that a new
participant has been successfully recruited. The adminis-
trator will hold sequential allocation tables for each
practice, independently generated from random num-
bers prior to recruitment. The administrator will allocate
all participants to intervention or control group in the
sequence that they are recruited and immediately send
each participant a standard letter informing them of
their group allocation. The administrator will also imme-
diately inform the appropriate WR Advisor of the con-
tact details of each newly allocated intervention group
participant and indicate that they are to be seen within
2 weeks. WR Advisors will be sent lists of control group
participants to assess 24 months later. The research
interviewers will not be notified of allocation status to
ensure that they remain blinded for the duration of the
study.
Study data
Data handling and record keeping
Study data will be entered directly into a secure database
during interviews for processing and management, and a
record of any changes made to the data post-entry will be
maintained. All personal information obtained for the
study will be held securely at Newcastle University and will
be treated as strictly confidential. Entry and verification of
twelve month data from self-completion questionnaires
will be outsourced to a data entry company.
Data collection and transfer in this study will comply
with UK NHS Research Ethics Service (NRES) http://www.
nres.npsa.nhs.uk/ and Caldicott guidelines http://www.dh.
gov.uk/en/Managingyourorganisation/Informationpolicy/
Patientconfidentialityandcaldicottguardians/DH_4100563
and the Data Protection Act (1998) http://www.dh.gov.uk/
en/Managingyourorganisation/Informationpolicy/Records-
management/DH_4000489. All patients will be allocated a
unique study identifier, which will be used on all data col-
lection forms and questionnaires to preserve confidential-
ity; names or addresses will not appear on completed
questionnaires or other data collection forms. Only a lim-
ited number of members of the research team will be able
to link the unique identifier to patient-identifiable details
(name, address and telephone number) which will be held
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on a password-protected database. All study documenta-
tion will be held in secure offices, not open to the public
and all members of the research team with access to identi-
fiable or anonymised data will operate to a signed code of
confidentiality. Transmission of original or hard copy
records (e.g. questionnaires, interview recordings) will be
by secure fax, post or hand delivery by members of the re-
search team or by the WR Advisors. Participants will be
informed in the patient information sheet about the trans-
fer of information to the research team and about levels of
access to patient identifiable data, and will be asked to con-
sent to this. Any data used in publications from the Do-
Well study will be fully anonymised; it will not be possible
to identify individual patients from such publications.
At the end of the study, original questionnaires, inter-
view transcripts and consent forms will be securely
archived for 15 years following publication of the last
paper or report from the study, in line with Sponsor pol-
icy and Newcastle Clinical Trials Unit (NCTU) standard
operating procedures. This will also allow any queries or
concerns about the data, conduct or conclusions of the
study to be resolved. Both sets of data will be archived
after 5 years. Anonymised data will be submitted to a
national archive collection.
Statistical analyses
Analyses of covariance and regression methods will
compare primary and secondary outcomes between
intervention and control groups at 24 months, adjusting
for baseline outcome values and any imbalance in other
covariates as appropriate.
Analyses will be by intention-to-treat. It will be neces-
sary to consider any difference in attrition rates, and the
non-randomness of the attrition, when comparing qual-
ity of life between the two groups. In the pilot RCT only
7/126 (5.5 %) died during the 24 month follow-up, so it
is thought unlikely that methods for joint modelling of
survival and longitudinal data will be necessary.
Exploratory sub-group analyses will also be under-
taken, for example to examine differences in outcome
between men and women, by age and by amount and
type of benefits received.
Health economic analyses
The economic evaluation will consist of a cost analysis
conducted from the perspectives of public sector ser-
vices (‘Do-Well’ service delivery costs), and that of the
Treasury (total cost of additional benefits paid out). The
mean change in benefits and the mean change in total
income of participants will also be calculated.
The cost analyses above will be used in conjunction
with study outcomes to produce a cost consequences
analysis [49]. If any significant change in EQ-5D health
utility scores can be attributed to the intervention, we
will undertake a cost-utility analysis [49]. The assump-
tions that underpin any such cost-utility analysis will be
subjected to one-way sensitivity analysis [50] and, in
addition, extensive probabilistic sensitivity analysis [50]
will be used with results presented in the form of cost-
effectiveness acceptability curves [50].
Qualitative analyses
All interviews will be digitally recorded (with permis-
sion) and transcribed verbatim. Data will analysed the-
matically following the Framework method [51] with
constant comparison [52] and deviant case analysis [53]
to enhance validity, supported by NVivo software [54].
Ethics
A favourable ethical opinion has been received from the
UK NHS National Research Ethics Service NRES Commit-
tee South West - Exeter (reference number: 11/SW/0260).
Discussion
This is an innovative trial designed to assess whether
welfare rights advice delivered in their own homes to
people from disadvantaged areas aged ≥60 years leads to
improvement in health-related quality of life. The study
is built on extensive prior research, which has led to
consideration of a range of ethical and methodological
issues. These are discussed in detail below.
Study design, level of randomisation, contamination and
dilution
An appropriate trial design is required, preferably with
both randomisation and concurrent controls. Individual
level randomisation is preferable to cluster randomisa-
tion (e.g. at general practice level) as it requires a smaller
sample size. The potential problem with individual level
allocation is that there may be ‘contamination’ between
intervention and control participants in the same general
practice. Where welfare rights advice is available from
an open access service delivered in the general practice
this is more likely to be the case. However, by using a
WR advisor who only sees patients in their own homes,
we found in our pilot RCT that contamination did not
occur; no control participants independently sought wel-
fare rights advice during a follow-up period, albeit of
only 6 months [7].
Equipoise and the control condition
A key consideration in designing the proposed trial was
whether there is genuine equipoise. Welfare rights ad-
vice is known to increase access to financial and material
resources in eligible clients. However, our systematic re-
view of published and grey literature indicated that there
is, as yet, no conclusive evidence that welfare rights ad-
vice leads to positive or negative changes in health [21].
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We discussed these findings with welfare rights advisors,
with directors of adult social services, with a selection of
GPs and with members of the public in our target age
group. We found each of these groups to be in equipoise
with regard to the proposed trial health outcomes. Hav-
ing established this, we also carefully considered the
issue of study design and the ideal and feasible control
conditions.
Ideally, controls should be adults as similar as possible
to intervention group participants, but should not re-
ceive welfare rights advice, nor claim or receive new
benefits, during the period of outcome follow-up. In
clinical trials, it is usual to withhold the intervention
from the control group because the health benefits of
the intervention are not proven (i.e. clinical equipoise
exists). Whilst this is the case with regard to the health
impacts of welfare rights advice, as indicated above there
is adequate evidence that welfare rights advice leads to
significant financial and material gains for a proportion
of recipients. Thus, it is considered ethically problematic
to identify that control group participants are eligible to
receive additional financial benefits, but either to keep
this information from them, or to tell them of their eligi-
bility but not give them advice or help with claims. To
circumvent this dilemma, we proposed that control par-
ticipants should not receive a welfare rights assessment
until the end of the trial period (i.e. following final out-
come measurement). The full intervention (i.e. a full
benefit assessment and active assistance with claims
until resolved) will then be offered.
There may be concerns about whether the welfare
rights advisors might feel tempted to offer benefits ad-
vice to controls before the two year ‘wait period’ has
elapsed. This will not be possible for the simple reason
that the welfare right advisors will not know the names
of controls until a few weeks before their benefits assess-
ment is due (i.e. two years after the their baseline assess-
ment). Control participants’ names will be held securely
by the study team over this period.
The proposed design thus avoids unfairly raising expec-
tations among controls. It also helps to avoid the potential
problem of contamination, which could arise if control par-
ticipants independently sought welfare advice (leading to
dilution of the outcome effect), although we will not make
any attempt to prevent this. The control condition is there-
fore, in effect, a ‘wait-list’ control, whereby the control
group will wait to receive the intervention 24 months after
the intervention group.
It is, of course, possible that some members of both
intervention and control groups may die during the pro-
posed 24 months follow-up period, and we would expect
this in the course of any prospective study of this age
group. In our pilot study, we recorded 7 deaths (4 interven-
tion group, 3 control group) after 24 months follow-up [7].
The proposed design of this RCT is fair because, at
present, this kind of intervention is not routinely avail-
able to primary care patients and is generally only avail-
able to those who seek such services or are referred to
them by a health or social care professional (e.g. a hos-
pital social worker); these options remain open to
patients in this trial. When targeted services are available
in primary care, they tend to be short term and ad hoc.
If we find any general practices in participating districts
with access to such services they will be excluded from
this trial. Genuine equipoise exists for the proposed
health-related outcomes because participants will not be
denied any entitlement that they would otherwise have
received and, at present, the health impact of the pro-
posed intervention is unknown [21].
Pragmatic versus explanatory
Not all participants in the intervention group will be eli-
gible for additional benefits, and for those who are, they
may receive variable amounts of financial and non-
financial benefits. Ideally, we would wish to examine the
health impact of receiving versus not receiving such bene-
fits, as well as examining the potential for a gradient of ef-
fect (‘dose-response’ relationship) by amount of benefit
received. However, to do so would require a substantially
larger sample size. In practice, therefore, the receipt of wel-
fare rights advice is the intervention we are evaluating
(rather than receipt of specific benefits), since ‘welfare
rights advice’ is the service being delivered. The proposed
trial is therefore a pragmatic (intention-to-treat) RCT of
this complex intervention. Nevertheless, we will also assess
the potential for exploratory sub-group analyses looking at
differential effects by participant characteristics (such as
age and sex), receipt/non-receipt of, and levels of any bene-
fits received. We anticipate that the trial will therefore con-
tribute both to answering the question of whether the
complex welfare rights advice intervention is effective in
improving health and to providing new evidence on the
theoretical question of whether increasing resources leads
to better health [9].
Length of follow-up
To enable accurate assessment of the health and social
effects of welfare rights advice, an appropriate length of
follow up is required. Experience from previous work
suggests that considerable time may elapse between first
advice session and receipt of new financial or material
benefits. Often this is between 3 and 6 months, but can
be longer if the case is not straightforward or if there is
an appeal. For example, in our pilot RCT, 45 % had
received their entitlements by 3 months after their wel-
fare assessment, 85 % after 6 months, 95 % after
9 months and 100 % by 12 months [7]. Given such
delays in receipt of benefits, as well as the fact that once
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received they need to be spent, it seems unlikely that
they will have substantial impacts on health within the
first 12 months. In our pilot, which was not adequately
powered for substantive analyses, we found no sugges-
tion of differences in health-related outcomes between
intervention and control groups after 6, 12 or 24 months
(although controls received the intervention after
6 months) [7]. Nevertheless, it seems likely that the
longer the delay between receipt of intervention and
measurement of outcomes, the greater the chance of
demonstrating a substantive effect on health.
To assess the acceptability of a range of delays in re-
ceiving the intervention among control group partici-
pants, we undertook an experiment in the context of a
focus group discussion with a representative sample of
low income, older people. To achieve this, simulations
of the RCT randomisation procedures were undertaken.
The first simulation concerned a typical drug trial and
participants were given different coloured sweets de-
pending on whether they were in the intervention or
control groups. Then, randomisation for the proposed
trial was simulated. The concept of equipoise, with re-
gard to the health impacts of welfare rights advice was
explained. Next, each group member was given an enve-
lope from which they found out whether they were in
the control group or the intervention group. If in the
intervention group, they were allocated various types of
benefit (e.g. Attendance Allowance +Council Tax Bene-
fit +Housing Benefit) and the monetary value of these
was revealed to them. We then talked through various
time delays until the control group would also receive
their welfare rights assessment and advice. The time
delays used were 3 months, 6 months, 9 months,
12 months, 18 months, 24 months, 36 months and
60 months. The initial response to the design was that it
was unfair on the control group. However, when it was
explained that: (i) while such services exist, they are not
routinely targeted at or delivered to all people aged over
60, but only available on referral or demand; (ii) the
findings of this study could influence the development
of such services, involving collaboration between health
and social services; and (iii) that a substantial ‘wait’ be-
tween intervention and control groups is needed to es-
tablish any differences in health outcome, the consensus
of the group was that a delay of 24 months would be ac-
ceptable in the context of the proposed trial. We have,
therefore, opted for a wait-list design for the proposed
RCT, with a 24 month follow-up period for the main
outcome assessment, followed immediately by delivery
of the full intervention to the control group.
Selection bias
In our pilot RCT, GPs wrote to random samples of
people aged over 60 years, inviting them to respond with
an indication of their willingness to participate in the
trial, i.e. to ‘opt in’ [7]. Using this method, 36 % initially
agreed to participate, 14 % declined to participate and
50 % failed to respond. Low levels of positive response
to an ‘opt in’ approach carry risks of participation bias
[55,56]. In their work on evaluating the impact of wel-
fare rights advice for the Department of Work and Pen-
sions [36], Sainsbury and colleagues routinely use an
‘opt out’ method of recruitment for similar populations
[57]. With the agreement of NRES we are using this type
of recruitment method in this trial. This should signifi-
cantly reduce the potential recruitment bias associated
with ‘opt in’ recruitment methods and significantly in-
crease the efficiency of trial recruitment.
Choice of outcome measures
Previously reported studies of the health effects of wel-
fare rights advice have restricted reported health out-
comes to general measures of health or psycho-social
functioning (such as the SF36 [29,30]) together with
measurement of financial gains. In our earlier qualitative
research among recipients of welfare rights advice, we
identified a range of potential benefits of advice: [22]
Health (improvements in anxiety, depression, insomnia,
reductions in medication or consultation, and health
promoting changes in smoking, diet, physical activity,
alcohol consumption)
Social (improvements in family or other relationships,
increased ability to work, ability to care for relatives,
etc.)
Financial (debt rescheduling and receipt of new
benefits, e.g. Attendance Allowance, Disability Living
Allowance, Mobility Allowance, Invalid Care
Allowance, Incapacity Benefit, Housing Benefit, Income
Support)
Material (e.g. access to free prescriptions, council tax
exemption, entitlement to respite care, meals on
wheels, re-housing or home modifications etc.)
The qualitative findings identified perceived benefits of
the intervention in terms of:
– increased affordability of necessities
– increased capacity to manage unexpected future
problems
– decrease in stress related to financial worries
– increased independence, including ability to travel,
shop, visit GP etc.
– increased ability to participate in family life and
society
We undertook further qualitative work with study par-
ticipants in our pilot RCT as well as collected planned
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outcome measures [8]. The pilot trial was not suffi-
ciently powered for substantive analyses, but the feasibil-
ity of measurements was good, and well tolerated by
older people.
These findings, together with those from recent,
similar research [37] point to the most significant
health-related impacts of welfare rights advice being on
quality of life, independence, social participation and
mental health. There is no single, ideal outcome measure
that captures all of these domains, but the CASP19
instrument [35,36], developed specifically with a view
to measuring quality of life in older people, comes
close and has been recommended by Corden et al as a
composite measure of the impact of welfare rights advice
[36]. It is a self-reported summative index, comprising
19 Likert scale items in 4 domains: control, autonomy,
self-realisation and pleasure [35]. Its performance has
been examined in several prospective studies, includ-
ing the English Longitudinal Study of Ageing (ELSA)
[48].
Generalisability
Our pilot trial was undertaken in one social services dis-
trict (Newcastle upon Tyne) and in 4 general practice
populations [7]. However, we know, from other work
and discussions locally, that service delivery in welfare
rights advice varies from area to area, as do general
practice populations. To enhance the potential generalis-
ability of the results, the RCT will therefore be under-
taken across a range of geographical and local authority
areas (including urban and rural) and general practices.
It is possible, indeed likely, that the present welfare re-
gime will change during the course of the trial. The pro-
posed intervention is not dependent on any particular
set of benefits and is adaptable to any new regime. This
adds to its future generalisability.
Target Population
Although we recognise that isolated older people who
are eligible for benefits may live in all areas, in order to
maximise the efficiency (and impact) of welfare rights
advice services provided through primary health care,
this RCT focuses on practice populations in socio-
economically disadvantaged areas. Eligibility for health-
related benefits (and failure to claim) increases with age,
particularly post-retirement, although there are other
key target groups such as single parents, non-claimants
most likely to be accessed through primary care are pre-
dominantly in older age groups [15,16,22,37]. This trial
therefore focuses on a predominantly post-retirement
population (aged ≥60 years), residing in areas of eco-
nomic deprivation.
Nature of the intervention
The intervention to be delivered in the proposed trial is
based on standard WR Advice services, of the type that
can be found across local authorities in England. Con-
ventionally, however, these services are available only on
demand or by referral. Thus, for example, an older per-
son admitted to hospital may be referred by a hospital
social worker, doctor or nurse for benefits assessment
prior to discharge. Only some services have undertaken
targeting of WR Advice at a population level [21]. Those
that have done so have found that there is a significant
level of under-claiming in the general population and in
particular among older people [18]. The proposed inter-
vention is therefore a modification of a standard WR
Advice service to target proactively a particularly vulner-
able population in which we know there are high levels
of under-claiming (i.e. over 60s in disadvantaged areas).
The only reliable population registers in England at a
local level are the primary care patient registration lists
held by GPs and PCTs, which will be used to sample this
target group selectively.
In our pilot RCT, we identified that efficiency and ef-
fectiveness (in terms of successful claims) could be max-
imised by making the service domiciliary, since a
substantial proportion of over-60s have limited mobility
and clients often need access during assessments to in-
formation kept at home [22,58]. Domiciliary visits also
proved more popular with clients. We also found that
welfare rights advisors need to provide ‘active assistance’
with claims, for example completing claim forms for cli-
ents, since this is a key barrier to claiming [8,20]. Lastly,
GPs need to have appropriate awareness of welfare enti-
tlements and, for health-related benefits in particular, an
understanding of the medical criteria on which decisions
are made so as to be able to support reasonable claims
effectively in medical assessments requested by the ben-
efits agency. Good communication between GPs and
welfare rights advisors is essential to facilitate this. In
our pilot RCT, we delivered education and training on
these issues to all GPs in participating practices [7,8], an-
other feature that is included in the proposed definitive
RCT.
Conclusions
We have presented the protocol for a definitive RCT of
domiciliary welfare rights advice for socio-economically
disadvantaged people aged ≥60 years recruited via pri-
mary health care, with embedded economic and qualita-
tive process evaluations. While relatively straightforward,
the design of the trial presented ethical and methodo-
logical challenges requiring a wait-list control group de-
sign. The study design is based on extensive prior
research, including a systematic review, pilot RCT and
qualitative studies [7,8,21]. Study recruitment will
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commence in April 2012 and the study is expected to re-
port in May 2015. If the health benefits of this interven-
tion are proven, targeted welfare rights advice services
could be extended to ensure widespread provision for
older people and other vulnerable groups, through col-
laboration between social services and primary care
trusts or commissioners. The results of this trial may
also have implications for the development of other
resource-based interventions to tackle inequalities.
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